Abstract
The chemokine, stromal cell-derived factor-1 (SDF-1) is a crucial regulator of stem cell homing and tethering, and potentiation of this pathway in leukaemias may contribute to the pathogenesis of the disease. A key second messenger in SDF-1 signal/response coupling is phosphatidylinositol 3,4,5-triphosphate [PtdIns(3,4,5)P3]. SDF-1 elevated PtdIns(3,4,5)P3 levels markedly in the multipotent FDCP-mix stem cell line. Similarly, transfection with BCR/ABL or TEL/PDGFRbeta leukaemogenic tyrosine kinases chronically elevated PtdIns(3,4,5)P3 levels. However, whilst an SDF-1 chemotactic response was observed in TEL/PDGFRbeta-transfected cells, in BCR/ABL cells this was markedly decreased, which was not due to Ras-pathway activation. Thus, multipotent cells can respond to SDF-1, despite chronic increases in this second messenger indicating that a discrete pool of SDF-1-stimulated PtdIns(3,4,5)P3 production drives the chemotactic response. To discern the mechanism for the differential effects of these oncogenes we considered subcellular localisation. As TEL/PDGFRbeta has a cytosolic location whilst BCR/ABL associates with actin, we removed the actin-binding domain from BCR/ABL. We observed relocation of BCR/ABL to the cytosol and increas...Continue Reading
References
Aug 25, 1989·Cell·R A Van EttenD Baltimore
Apr 22, 1994·Cell·T R GolubD G Gilliland
Oct 1, 1993·The Journal of Clinical Investigation·M WetzlerR Kurzrock
Aug 29, 1996·Nature·C C BleulT A Springer
Aug 29, 1996·Nature·E OberlinB Moser
Jan 1, 1997·Acta Haematologica·C M VerfaillieR Bhatia
Jun 20, 1998·Nature·K TachibanaT Nagasawa
Jun 20, 1998·Nature·Y R ZouD R Littman
Aug 15, 1998·Oncogene·A PierceA D Whetton
Feb 5, 1999·Science·A PeledT Lapidot
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Dec 10, 1999·The Biochemical Journal·A GrayC P Downes
Dec 22, 1999·The Journal of Clinical Investigation·C H KimH E Broxmeyer
Jan 14, 2000·Leukemia Research·A P McGlynnR L Darley
Dec 15, 2000·Oncogene·A PierceA D Whetton
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·F C YangD A Williams
Aug 30, 2001·Seminars in Hematology·O Witte
Dec 1, 2001·Science·D E WrightI L Weissman
Dec 26, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Miguel Vicente-ManzanaresFrancisco Sánchez-Madrid
Jan 25, 2002·Blood·Francesco OnidaMiloslav Beran
Jun 26, 2002·Oncogene·Andrew PierceAnthony D Whetton
Sep 5, 2002·The Journal of Experimental Medicine·Andrzej PtasznikAlan M Gewirtz
Dec 12, 2002·Oncogene·Jason A WertheimWarren S Pear
Jun 28, 2003·Blood·Anthony D WhettonElaine Spooncer
Nov 19, 2003·Biochemical and Biophysical Research Communications·Reinhard HenschlerDietrich Möbest
Feb 7, 2004·Blood·Caroline A EvansAnthony D Whetton
May 27, 2004·Blood·Yoshio KatayamaPaul S Frenette
Jun 24, 2004·Blood·Shawn D PelletierShaoguang Li
Dec 9, 2004·Blood·Russell S Taichman
Dec 22, 2004·The Journal of Biological Chemistry·Masato MoriguchiJohn J O'Shea
Apr 26, 2005·Molecular & Cellular Proteomics : MCP·Richard D UnwinAnthony D Whetton
Aug 19, 2005·Leukemia·H G HamzahA D Whetton
Feb 21, 2006·British Journal of Haematology·N Underhill-DayP J Owen-Lynch
Nov 17, 2006·Cancer Research·Nicholas Underhill-Day, John K Heath
Citations
Dec 14, 2012·Acta Haematologica·Jyoti P Chaudhuri, Joachim U Walther
Jan 15, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael AnsorgeTilo Pompe
Aug 30, 2008·British Journal of Haematology·Drew ProvanRoberto Stasi
Jun 25, 2008·British Journal of Haematology·Bethan Psaila, James B Bussel
Oct 24, 2007·Molecular & Cellular Proteomics : MCP·Andrew PierceAnthony D Whetton
Sep 3, 2013·Molecular & Cellular Proteomics : MCP·Andrew J K WilliamsonAnthony D Whetton